isirv

About Guides FAQs

Font Size

SCREEN

Profile

Direction

Menu Style

Apply Reset  

Hot News  new flash

isirv, in association with Wiley-Blackwell, are seeking to appoint a new 'Editor-in-Chief' for the isirv journal 'Influenza and Other Respiratory Viruses' to succeed the current editor, Dr Alan Hampson, when he retires towards the end of 2013.  Further information on the role, and how to apply, are available in the news section.


Abstract submission and registration deadlines for Options VIII extended until 19th June.  Submit your abstract for the conference here.


MERS-CoV: information and links to other sources of information on this evolving situation is available through the news section. 

influenza A(H7N9) in China: information and links to other sources of information is available through the news section. 


Effective with the 2013 Volume, Influenza and other Respiratory Viruses will be published in an Online Only format. No printed issue will be produced but authors will still be able to order offprints of their own articles. Further information is available here

irv if 2011 banner advert

International Society for Influenza and other Respiratory Virus Diseases: isirv

isirv is an independent and international scientific professional society promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. It aims to provide opportunities for the exchange of information and for international collaboration between those with a scientific interest in any aspect of influenza and other respiratory viral infections. Thus, its activities include the organisation of scientific meetings, promotion of scientific and clinical training, dissemination of information on the impact of acute respiratory viral disease both locally and globally, and publication of scientific information, notably through the journal Influenza and other Respiratory Diseases. The society has lead responsibility for organizing the Options for the Control of Influenza conferences, the largest international gatherings exclusively devoted to influenza prevention, control and treatment, including seasonal flu and pandemic preparedness. Read More

isirv Antiviral Group (isirv-AVG)

The isirv Antiviral Group (isirv-AVG) was established as a special interest group of isirv at the time of merger in April 2011 of the former Neuraminidase Inhibitor Susceptibility Network (NISN) with isirv.

Its specific objectives are to promote understanding of the clinical use of antivirals against respiratory viruses, collate and provide up to date information on the emergence of antiviral resistance, and communicate expert commentary on preclinical and clinical development of potential novel/new antivirals in this area. Read More

ISIRV IS REGISTERED IN THE UNITED KINGDOM BOTH AS A CHARITY (NO.1118829) AND AS A COMPANY LIMITED BY GUARANTEE, THE FORMAT IN UK COMPANY LAW FOR NOT-FOR-PROFIT ORGANISATIONS, (NO. 06021083)